Table 2. Relationships between the acute-phase proteins and c-f PWV.
| Model 1 | |||||
| Geometric means (n) | Geometric means (n) | Geometric means (n) | Geometric means (n) | ||
| Q1 | Q2 | Q3 | Q4 | p for trend | |
| Ceruloplasmin | 10.13 (558) | 10.04 (606) | 10.22 (597) | 10.40* (577) | 0.004 |
| Alpha-1-antitrypsin | 10.05 (595) | 10.12 (505) | 10.26 (673) | 10.34** (565) | 0.004 |
| Orosomucoid | 10.05 (645) | 10.00 (531) | 10.21 (577) | 10.52*** (585) | <0.001 |
| Haptoglobin | 10.04 (633) | 10.20 (562) | 10.21 (559) | 10.35** (584) | 0.006 |
| Complement-C3 | 9.89 (577) | 10.08 (595) | 10.27*** (586) | 10.55*** (580) | <0.001 |
| CRP | 9.84 (534) | 10.04 (610) | 10.36*** (607) | 10.52*** (587) | <0.001 |
| Model 2 | |||||
| Q1 | Q2 | Q3 | Q4 | p for trend | |
| Ceruloplasmin | 10.18 | 10.05 | 10.21 | 10.36 | 0.035 |
| Alpha-1-antitrypsin | 10.04 | 10.16 | 10.27* | 10.32* | 0.007 |
| Orosomucoid | 10.20 | 10.03 | 10.18 | 10.37 | 0.058 |
| Haptoglobin | 10.12 | 10.26 | 10.17 | 10.25 | 0.440 |
| Complement-C3 | 10.06 | 10.14 | 10.24 | 10.35* | 0.012 |
| CRP | 9.96 | 10.10 | 10.33** | 10.37*** | <0.001 |
* p<0.05
** p<0.01
***p<0.001
Ln transformed values were used to calculate the p-values with Q1 as the reference group. Model 1: Adjusted for age, sex, heart rate, mean arterial pressure (MAP) at follow-up. Model 2: Adjusted for age, sex, heart rate, mean arterial pressure (MAP) at follow-up, and baseline age, smoking habits, systolic blood pressure, HDL, LDL, waist circumference, diabetes, use of anti-hypertensive medication and use of lipid lowering medication